Use your antibodies-online credentials, if available.
PCDH17 belongs to the protocadherin gene family, a subfamily of the cadherin superfamily. 再加上，我们可以发PCDH17 蛋白 (4) 和 PCDH17 试剂盒 (2)和数多这个蛋白质的别的产品。
Showing 10 out of 61 products:
Cow (Bovine) Polyclonal PCDH17 Primary Antibody for WB - ABIN2785751
Szafranski, Schindler, Taudien, Hiller, Huse, Jahn, Schreiber, Backofen, Platzer: Violating the splicing rules: TG dinucleotides function as alternative 3' splice sites in U2-dependent introns. in Genome biology 2008
Mouse (Murine) Polyclonal PCDH17 Primary Antibody for ELISA, WB - ABIN4347946
Giefing, Zemke, Brauze, Kostrzewska-Poczekaj, Luczak, Szaumkessel, Pelinska, Kiwerska, Tönnies, Grenman, Figlerowicz, Siebert, Szyfter, Jarmuz: High resolution ArrayCGH and expression profiling identifies PTPRD and PCDH17/PCH68 as tumor suppressor gene candidates in laryngeal squamous cell carcinoma. in Genes, chromosomes & cancer 2011
Methylation of PCDH17 could play an important role in development and progression of high-grade serous ovarian carcinoma (HGSOC)and has potential to become a target in the search for new clinical biomarkers
PCDH17 methylation in serum is a potential prognostic biomarker for patients with renal cell carcinoma after surgery.
PCDH17 functions as a tumor suppressor inhibiting Wnt/beta-catenin signaling and metastasis in breast cancer but is frequently methylated in primary tumors which could be a potential biomarker.
Aberrant methylation of protocadherin 17 is associated with acute lymphoblastic leukemia.
PCDH-17 inhibited metastasis via EGFR/MEK/ERK signaling pathway.
DNA methylation in a combination of POU4F2/PCDH17 has yielded the highest sensitivity and specificity of 90.00% and 93.96% in all the 312 individuals, showing the capability of detecting bladder cancer effectively among pathologically varied sample groups.
PCDH17 methylation in serum is a frequent event in early-stage prostate cancer, and it is an independent predictor of BCR after radical prostatectomy
PCDH17 methylation occurred more frequently and was associated with malignant clinicopathological characteristics and poor prognosis in clear cell renal cell carcinoma patients
PCDH17 promoter methylation is closely associated with bladder cancer malignancy and may be used as an independent predictor of clinical outcomes in patients with bladder cancer.
PCDH17 promoter methylation was significantly associated with malignant behaviour and poor prognosis of bladder cancer
This study demonistrated that critical role for PCDH17 in the synaptic development of specific corticobasal ganglia circuits and suggest the involvement of PCDH17 in such circuits in depressive behaviors.
PCDH17 acts as a tumour suppressor, exerting its anti-proliferative activity through inducing apoptosis and autophagy, and is frequently silenced in gastric and colorectal cancers.
Our study clearly demonstrates that PCDH17 is transcriptionally downregulated in gastric cancer due to aberrant promoter CpG island methylation
statistical significant downregulation of PCDH17/PCH68 and PTPRD was observed
results suggest that silencing of PCDH17 expression through hypermethylation of the promoter or other mechanisms leads to loss of its tumour-suppressive activity, which may be a factor in the carcinogenesis of a subgroup of ESCCs
Azoospermic testis showed down-regulation of CDH18 and PCDH17.
the apparent occurrence of an unusual TG 3' splice site in intron 2 is discussed
This gene belongs to the protocadherin gene family, a subfamily of the cadherin superfamily. The encoded protein contains six extracellular cadherin domains, a transmembrane domain, and a cytoplasmic tail differing from those of the classical cadherins. The encoded protein may play a role in the establishment and function of specific cell-cell connections in the brain.